# A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma

> **NCT01890590** · NA · RECRUITING · sponsor: **Beth Israel Deaconess Medical Center** · enrollment: 46 (estimated)

## Conditions studied

- Renal Cell Carcinoma

## Interventions

- **DEVICE:** CyberKnife

## Key facts

- **NCT ID:** NCT01890590
- **Lead sponsor:** Beth Israel Deaconess Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2013-07
- **Primary completion:** 2025-01
- **Final completion:** 2025-03
- **Target enrollment:** 46 (ESTIMATED)
- **Last updated:** 2024-08-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01890590

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01890590, "A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01890590. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*